Diploma (LON:DPLM) Price Target Raised to GBX 3,800 at Berenberg Bank

Diploma (LON:DPLM) had its price objective raised by Berenberg Bank from GBX 3,500 ($43.79) to GBX 3,800 ($47.54) in a research note issued to investors on Monday morning, Digital Look reports. They currently have a buy rating on the stock.

Separately, Shore Capital restated a buy rating on shares of Diploma in a report on Monday. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Diploma presently has a consensus rating of Hold and a consensus price target of GBX 3,028.57 ($37.89).

Diploma Price Performance

Shares of Diploma stock traded down GBX 16 ($0.20) on Monday, hitting GBX 3,342 ($41.81). 111,299 shares of the company were exchanged, compared to its average volume of 257,755. The stock has a market capitalization of £4.48 billion, a price-to-earnings ratio of 3,559.57, a price-to-earnings-growth ratio of 2.82 and a beta of 0.68. The company has a 50-day moving average price of GBX 2,967.34 and a 200 day moving average price of GBX 3,025.20. Diploma has a 1-year low of GBX 2,524.50 ($31.58) and a 1-year high of GBX 3,400 ($42.54). The company has a quick ratio of 0.80, a current ratio of 1.87 and a debt-to-equity ratio of 33.34.

Diploma Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, February 2nd. Shareholders of record on Thursday, January 18th will be paid a dividend of GBX 40 ($0.50) per share. This is a boost from Diploma’s previous dividend of $16.50. The ex-dividend date is Thursday, January 18th. This represents a yield of 1.32%. Diploma’s dividend payout ratio (DPR) is 5,851.06%.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies clinical diagnostics instrumentation and products, instrumentation and consumables, specialty surgical devices, and related consumables and services to public hospitals, private clinics, pathology laboratories, scientific research, and medical segments; surgical equipment for hospital operating rooms; and distributes laboratory diagnostics, specialty medical devices, devices, equipment, and patient monitoring technologies used in operating theatres, as well as medically supervised nutrition.